Champions Oncology (CSBR) Change in Receivables (2013 - 2026)
Champions Oncology's (CSBR) quarterly Change in Receivables came in at $414000.0 in Q3 2026, up 123.54% year-over-year from $185205.0 in Q3 2025, and down 65.06% on a QoQ basis from $1.2 million in Q2 2026.
Powered by 
Analysis
Champions Oncology (CSBR) Change in Receivables (2013 - 2026) Analysis & Trends
Champions Oncology (CSBR) has 14 years of Change in Receivables data on file, last reported at $414000.0 in Q3 2026.
- On a quarterly basis, Change in Receivables rose 123.54% year-over-year to $414000.0 in Q3 2026; TTM through Jul 2026 was $4.2 million, a 1625.21% increase from a year earlier, with the FY2026 full-year figure at $2.0 million, up 39.42% from the prior year.
- Change in Receivables for Q3 2026 stood at $414000.0, down from $1.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $5.3 million in Q1 2025 and bottomed at -$4.5 million in Q2 2025.
- Historically, Change in Receivables has averaged $317473.7 across 5 years, with a median of $372000.0 in 2022.
- The widest annual swing landed in 2023, when Change in Receivables slumped 353.49%; it then surged 2500.0% in 2024.
- Year by year, Change in Receivables stood at -$276000.0 in 2022, then tumbled by 317.39% to -$1.2 million in 2023, then surged by 206.68% to $1.2 million in 2024, then surged by 69.08% to $2.1 million in 2025, then sank by 80.08% to $414000.0 in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $414000.0 in Q3 2026, $1.2 million in Q2 2026, and $498000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 47.18 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -43.54 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 21.82 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -3.71 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 414,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 416,693.85 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 414,000.00 |
| Apr 30, 2026 | 1.19 Mn |
| Jan 31, 2026 | 498,000.00 |
| Oct 31, 2025 | 2.08 Mn |
| Jul 31, 2025 | -1.76 Mn |
| Apr 30, 2025 | -4.50 Mn |
| Jan 31, 2025 | 5.27 Mn |
| Oct 31, 2024 | 1.23 Mn |
| Jul 31, 2024 | -565,000.00 |
| Apr 30, 2024 | 1.79 Mn |
| Jan 31, 2024 | 250,000.00 |
| Oct 31, 2023 | -1.15 Mn |
| Jul 31, 2023 | 1.10 Mn |
| Apr 30, 2023 | 69,000.00 |
| Jan 31, 2023 | -943,000.00 |
| Oct 31, 2022 | -276,000.00 |
| Jul 31, 2022 | -158,000.00 |
| Apr 30, 2022 | 1.13 Mn |
| Jan 31, 2022 | 372,000.00 |
| Oct 31, 2021 | 496,000.00 |